All slots are booked for the doctor today. Please check for another day or call us at 1800 102 4647.
Next Available Slot
Doctor Consultation Charges (Video Consultation) - Rs. Price not Available/-
Confirm Appointment
You will receive an SMS with a verification code on this number.
Are you new to hospital ?
Go Back
We have sent you an OTP on
+91 8745360000
Resend OTP
Did not receive OTP? You can request for another OTP click resend option
Go BackBook Appointment
Your appointment is confirmed.
The details will be shared via Email & SMS
Note :Temporary visitor restriction, only one attendant is permitted with the patient. Your cooperation is solicited.
Confirm Appointment
Are you new to hospital?
Go Back
Go Back
Your Appointment will be confirmed after generating Pre Registration ID and making payment for consultation now.
Patient Registration Details
1
Basic Details
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
2
Other Details
Declaration
Go Back
Patient Registration Details
Basic Details
Other Details
3
Declaration
Consent and Declaration
I, the undersigned, declare that the above information provided by me are true to the best of my knowledge and hereby provide my consent to the Manipal Hospital to provide Medical Care, Treatment, Conduct Investigations and Diagnostic Procedures necessary for the above mentioned individual by Medical Staff at Manipal Hospital. I, also understand that Manipal Hospital will not be responsible for any loss, damage or theft of any Personal Property/Belongings of Me/Patient/Visitors within the Hospital Premises. Including Patients rooms and Parking area. I agree to follow all the rules and regulations of Hospital and clear all the expenses incurred for My/Patient treatment on time as per the Terms and Conditions of Manipal Hospital,
I would like to receive Self/Patient reports by Email
I would like to receive Hospital Info Alerts reports by Email
If consent provided on behalf of the patient.
I hereby give my consent and authorize Manipal Hospitals to process, store,use,disclose my personal or sensitive information/data collected as per Manipal Privacy Policy
Go Back
We have sent you an OTP on
Resend OTP
Did not receive an OTP? You Can Request For Another OTP Click Resend Option
Go Back
Patient Details
×
ALREADY APPOINTMENT IS AVAILABLE FOR THIS PATIENT
×
We see that your email address is not updated in our system. Hence, we couldn't able to complete this transaction.We request you to call our appointment helpline number: 1800 102 5555 to book an appointment.
President, Indian Rheumatology Association (2021-2023).
Scientific committee chairman: IRACON 2021.
Talks & Publications
Dapsone in Rheumatic Diseases (Review) Journal of Indian Rheumatology Association (JIRA) 1994:2(4): 177-179.
Interferon therapy in Rheumatic diseases (Review) JIRA 1995:3(1) 33-35.
Gastrointestinal tract in Rheumatic diseases (Review)-Antiseptic 1995
1995:92(9);336-337.
Aggressive therapy in Neuropsychiatric Lupus-Should NPSLE be treated as aggressively as renal Lupus-JIRA 1996;4(2);61-63.
Rheumatological manifestation of diabetes mellitus-Karnataka journal
of medical sciences (KJMS) April-June 2002.
Rheumatological manifestations in Hypothyroidism-JK Science Vol 3: no 3, July-September 2001.
International scleroderma symposium: July 16-17, 2016, Bengaluru. Indian J Rheumatol 2016;11:163-4.
Preface: Soft Tissue Rheumatism Indian Journal of Rheumatology 9 ( 2 0 1 4 ) S 1eS 2.
Approach to a patient with soft tissue rheumatic pain.. Ind J Rheumatol. 2014;9:S3eS5.
Polymyalgia Rheumatica and Giant cell arteritis. JIM 3R; vol 5 issue 1: Jan-March 17. 28-31.
The spectrum of clinical and immunological features of systemic rheumatic diseases in a referral hospital: Juvenile Dermatomyositis/Polymyositis. JIRA 1995:3(4):141-145.
Short report: Giant cell arteritis A Clinical and Pathological Study National medical journal of India; 2010 vol 23;1; 18-20.
An unusual presentation of Wegener’s granulomatosis during pregnancy. IJRCI. 2013;1(1):CS4 (22 June 2013).
Presentation of Ewing’s sarcoma as unilateral sacroiliitis. IJRCI. 2013;1(1):CS3. (21 May 2013).
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study.
Int J Rheum Dis. 2016 Nov;19(11):1083-1092. doi: 10.1111/1756-185X.12927.
Phenotypic Variability in Majeed Syndrome. J Rheumatol 2016;43:6; doi:10.3899/jrheum.151193.
Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study. Int J Rheum Dis. 2016 Jul 25. doi: 10.1111/1756-185X.12908. [Epub ahead of print].
Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity;(KRAC) study. Int J Rheum Dis. 2016 Dec 10. doi: 10.1111/1756-185X.12957. [Epub ahead of print].
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clin Rheumatol. 2016 Dec 19. [Epub ahead of print].
Comorbidities and related factors in rheumatoid arthritis patients in south India-KRAC study. Rheumatismo 2017;69(2):47-58.
Das P, Moorthy A, Dharmanand B. Rheumatology training in India compared to the United Kingdom. Indian J Rheumatol [serial online] 2018 [cited 2018 Jun 7];13:113-6. Available from: http://www.indianjrheumatol.com/text.asp?2018/13/2/113/222116.
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
August 2018 International Journal of Rheumatic Diseases
DOI: 10.1111/1756-185X.13376
International Scleroderma Symposium: July 16–17, 2016, Bengaluru: Indian J Rheumatol 2016;11:163-4.
SAT0234 Prospective single centre study of effectiveness of upfront rituximab and mycophenolate with minimum steroid in SLE
June 2017Annals of the Rheumatic Diseases 76(Suppl 2):862.1-862
DOI: 10.1136/annrheumdis-2017-eular.2902
Conference: Annual European Congress of Rheumatology, 14–17 June, 2017
Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India. Rheumatology International
https://doi.org/10.1007/s00296-019-04245-4
Worsening of posterior scleritis and orbital pseudotumor in a patient with Granulomatosis polyangiitis with a rituximab‑A case report. Indian J Ophthalmol 2020;68:XX-XX
Expert Panel Consensus Statements on the Optimal Usage of Rituximab
for the Management of Rheumatoid Arthritis in India. Indian Journal Of Rheumatology; 10.4103/injr.injr_69_21 (2021).
Do all Patients with Rheumatic Diseases have a Higher Risk of COVID 19? Initial Results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC). Indian J Rheumatol 2021;16:164-8.
A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic Diseases; DOI: https://doi.org/10.21203/rs.3.rs-805748/v1 (Preprint).
Effectiveness of myofascial release on pain, sleep, and quality of life in
patients with fibromyalgia syndrome: A systematic review. Complementary Therapies in Clinical Practice 45 (2021) 101477.
A dire need to create awareness about rheumatological diseases - Dr. BG Dharmanand, Senior Consultant - Rheumatology, Manipal Hospital Millers Road. Click Here
Languages Spoken
English
Tamil
Kannada
Telugu
Hindi
Fellowship & Membership
IMA
API
IAPMR
Geriatric society.
Society of orthopaedic medicine.
IACFS-ME
Fascia research society.
IOF
Indian Rheumatology association.
Field of Expertise
Arthritis
Multi-system autoimmune diseases
Osteoporosis
Fibromyalgia and Musculoskeletal medicine
Awards & Achievements
President, Indian Rheumatology Association (2021-2023).
Scientific committee chairman: IRACON 2021.
Talks & Publications
Dapsone in Rheumatic Diseases (Review) Journal of Indian Rheumatology Association (JIRA) 1994:2(4): 177-179.
Interferon therapy in Rheumatic diseases (Review) JIRA 1995:3(1) 33-35.
Gastrointestinal tract in Rheumatic diseases (Review)-Antiseptic 1995
1995:92(9);336-337.
Aggressive therapy in Neuropsychiatric Lupus-Should NPSLE be treated as aggressively as renal Lupus-JIRA 1996;4(2);61-63.
Rheumatological manifestation of diabetes mellitus-Karnataka journal
of medical sciences (KJMS) April-June 2002.
Rheumatological manifestations in Hypothyroidism-JK Science Vol 3: no 3, July-September 2001.
International scleroderma symposium: July 16-17, 2016, Bengaluru. Indian J Rheumatol 2016;11:163-4.
Preface: Soft Tissue Rheumatism Indian Journal of Rheumatology 9 ( 2 0 1 4 ) S 1eS 2.
Approach to a patient with soft tissue rheumatic pain.. Ind J Rheumatol. 2014;9:S3eS5.
Polymyalgia Rheumatica and Giant cell arteritis. JIM 3R; vol 5 issue 1: Jan-March 17. 28-31.
The spectrum of clinical and immunological features of systemic rheumatic diseases in a referral hospital: Juvenile Dermatomyositis/Polymyositis. JIRA 1995:3(4):141-145.
Short report: Giant cell arteritis A Clinical and Pathological Study National medical journal of India; 2010 vol 23;1; 18-20.
An unusual presentation of Wegener’s granulomatosis during pregnancy. IJRCI. 2013;1(1):CS4 (22 June 2013).
Presentation of Ewing’s sarcoma as unilateral sacroiliitis. IJRCI. 2013;1(1):CS3. (21 May 2013).
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study.
Int J Rheum Dis. 2016 Nov;19(11):1083-1092. doi: 10.1111/1756-185X.12927.
Phenotypic Variability in Majeed Syndrome. J Rheumatol 2016;43:6; doi:10.3899/jrheum.151193.
Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study. Int J Rheum Dis. 2016 Jul 25. doi: 10.1111/1756-185X.12908. [Epub ahead of print].
Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity;(KRAC) study. Int J Rheum Dis. 2016 Dec 10. doi: 10.1111/1756-185X.12957. [Epub ahead of print].
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clin Rheumatol. 2016 Dec 19. [Epub ahead of print].
Comorbidities and related factors in rheumatoid arthritis patients in south India-KRAC study. Rheumatismo 2017;69(2):47-58.
Das P, Moorthy A, Dharmanand B. Rheumatology training in India compared to the United Kingdom. Indian J Rheumatol [serial online] 2018 [cited 2018 Jun 7];13:113-6. Available from: http://www.indianjrheumatol.com/text.asp?2018/13/2/113/222116.
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
August 2018 International Journal of Rheumatic Diseases
DOI: 10.1111/1756-185X.13376
International Scleroderma Symposium: July 16–17, 2016, Bengaluru: Indian J Rheumatol 2016;11:163-4.
SAT0234 Prospective single centre study of effectiveness of upfront rituximab and mycophenolate with minimum steroid in SLE
June 2017Annals of the Rheumatic Diseases 76(Suppl 2):862.1-862
DOI: 10.1136/annrheumdis-2017-eular.2902
Conference: Annual European Congress of Rheumatology, 14–17 June, 2017
Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India. Rheumatology International
https://doi.org/10.1007/s00296-019-04245-4
Worsening of posterior scleritis and orbital pseudotumor in a patient with Granulomatosis polyangiitis with a rituximab‑A case report. Indian J Ophthalmol 2020;68:XX-XX
Expert Panel Consensus Statements on the Optimal Usage of Rituximab
for the Management of Rheumatoid Arthritis in India. Indian Journal Of Rheumatology; 10.4103/injr.injr_69_21 (2021).
Do all Patients with Rheumatic Diseases have a Higher Risk of COVID 19? Initial Results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC). Indian J Rheumatol 2021;16:164-8.
A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic Diseases; DOI: https://doi.org/10.21203/rs.3.rs-805748/v1 (Preprint).
Effectiveness of myofascial release on pain, sleep, and quality of life in
patients with fibromyalgia syndrome: A systematic review. Complementary Therapies in Clinical Practice 45 (2021) 101477.
A dire need to create awareness about rheumatological diseases - Dr. BG Dharmanand, Senior Consultant - Rheumatology, Manipal Hospital Millers Road. Click Here
Field of Expertise
Arthritis
Multi-system autoimmune diseases
Osteoporosis
Fibromyalgia and Musculoskeletal medicine
Fellowship & Membership
IMA
API
IAPMR
Geriatric society.
Society of orthopaedic medicine.
IACFS-ME
Fascia research society.
IOF
Indian Rheumatology association.
Languages Spoken
English
Tamil
Kannada
Telugu
Hindi
Awards & Achievements
President, Indian Rheumatology Association (2021-2023).
Scientific committee chairman: IRACON 2021.
Talks & Publications
Dapsone in Rheumatic Diseases (Review) Journal of Indian Rheumatology Association (JIRA) 1994:2(4): 177-179.
Interferon therapy in Rheumatic diseases (Review) JIRA 1995:3(1) 33-35.
Gastrointestinal tract in Rheumatic diseases (Review)-Antiseptic 1995
1995:92(9);336-337.
Aggressive therapy in Neuropsychiatric Lupus-Should NPSLE be treated as aggressively as renal Lupus-JIRA 1996;4(2);61-63.
Rheumatological manifestation of diabetes mellitus-Karnataka journal
of medical sciences (KJMS) April-June 2002.
Rheumatological manifestations in Hypothyroidism-JK Science Vol 3: no 3, July-September 2001.
International scleroderma symposium: July 16-17, 2016, Bengaluru. Indian J Rheumatol 2016;11:163-4.
Preface: Soft Tissue Rheumatism Indian Journal of Rheumatology 9 ( 2 0 1 4 ) S 1eS 2.
Approach to a patient with soft tissue rheumatic pain.. Ind J Rheumatol. 2014;9:S3eS5.
Polymyalgia Rheumatica and Giant cell arteritis. JIM 3R; vol 5 issue 1: Jan-March 17. 28-31.
The spectrum of clinical and immunological features of systemic rheumatic diseases in a referral hospital: Juvenile Dermatomyositis/Polymyositis. JIRA 1995:3(4):141-145.
Short report: Giant cell arteritis A Clinical and Pathological Study National medical journal of India; 2010 vol 23;1; 18-20.
An unusual presentation of Wegener’s granulomatosis during pregnancy. IJRCI. 2013;1(1):CS4 (22 June 2013).
Presentation of Ewing’s sarcoma as unilateral sacroiliitis. IJRCI. 2013;1(1):CS3. (21 May 2013).
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study.
Int J Rheum Dis. 2016 Nov;19(11):1083-1092. doi: 10.1111/1756-185X.12927.
Phenotypic Variability in Majeed Syndrome. J Rheumatol 2016;43:6; doi:10.3899/jrheum.151193.
Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study. Int J Rheum Dis. 2016 Jul 25. doi: 10.1111/1756-185X.12908. [Epub ahead of print].
Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity;(KRAC) study. Int J Rheum Dis. 2016 Dec 10. doi: 10.1111/1756-185X.12957. [Epub ahead of print].
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clin Rheumatol. 2016 Dec 19. [Epub ahead of print].
Comorbidities and related factors in rheumatoid arthritis patients in south India-KRAC study. Rheumatismo 2017;69(2):47-58.
Das P, Moorthy A, Dharmanand B. Rheumatology training in India compared to the United Kingdom. Indian J Rheumatol [serial online] 2018 [cited 2018 Jun 7];13:113-6. Available from: http://www.indianjrheumatol.com/text.asp?2018/13/2/113/222116.
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
August 2018 International Journal of Rheumatic Diseases
DOI: 10.1111/1756-185X.13376
International Scleroderma Symposium: July 16–17, 2016, Bengaluru: Indian J Rheumatol 2016;11:163-4.
SAT0234 Prospective single centre study of effectiveness of upfront rituximab and mycophenolate with minimum steroid in SLE
June 2017Annals of the Rheumatic Diseases 76(Suppl 2):862.1-862
DOI: 10.1136/annrheumdis-2017-eular.2902
Conference: Annual European Congress of Rheumatology, 14–17 June, 2017
Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India. Rheumatology International
https://doi.org/10.1007/s00296-019-04245-4
Worsening of posterior scleritis and orbital pseudotumor in a patient with Granulomatosis polyangiitis with a rituximab‑A case report. Indian J Ophthalmol 2020;68:XX-XX
Expert Panel Consensus Statements on the Optimal Usage of Rituximab
for the Management of Rheumatoid Arthritis in India. Indian Journal Of Rheumatology; 10.4103/injr.injr_69_21 (2021).
Do all Patients with Rheumatic Diseases have a Higher Risk of COVID 19? Initial Results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC). Indian J Rheumatol 2021;16:164-8.
A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic Diseases; DOI: https://doi.org/10.21203/rs.3.rs-805748/v1 (Preprint).
Effectiveness of myofascial release on pain, sleep, and quality of life in
patients with fibromyalgia syndrome: A systematic review. Complementary Therapies in Clinical Practice 45 (2021) 101477.
A dire need to create awareness about rheumatological diseases - Dr. BG Dharmanand, Senior Consultant - Rheumatology, Manipal Hospital Millers Road. Click Here
Awards & Achievements
President, Indian Rheumatology Association (2021-2023).
Scientific committee chairman: IRACON 2021.
Fellowship & Membership
IMA
API
IAPMR
Geriatric society.
Society of orthopaedic medicine.
IACFS-ME
Fascia research society.
IOF
Indian Rheumatology association.
Field of Expertise
Arthritis
Multi-system autoimmune diseases
Osteoporosis
Fibromyalgia and Musculoskeletal medicine
Languages Spoken
English
Tamil
Kannada
Telugu
Hindi
Talks & Publications
Dapsone in Rheumatic Diseases (Review) Journal of Indian Rheumatology Association (JIRA) 1994:2(4): 177-179.
Interferon therapy in Rheumatic diseases (Review) JIRA 1995:3(1) 33-35.
Gastrointestinal tract in Rheumatic diseases (Review)-Antiseptic 1995
1995:92(9);336-337.
Aggressive therapy in Neuropsychiatric Lupus-Should NPSLE be treated as aggressively as renal Lupus-JIRA 1996;4(2);61-63.
Rheumatological manifestation of diabetes mellitus-Karnataka journal
of medical sciences (KJMS) April-June 2002.
Rheumatological manifestations in Hypothyroidism-JK Science Vol 3: no 3, July-September 2001.
International scleroderma symposium: July 16-17, 2016, Bengaluru. Indian J Rheumatol 2016;11:163-4.
Preface: Soft Tissue Rheumatism Indian Journal of Rheumatology 9 ( 2 0 1 4 ) S 1eS 2.
Approach to a patient with soft tissue rheumatic pain.. Ind J Rheumatol. 2014;9:S3eS5.
Polymyalgia Rheumatica and Giant cell arteritis. JIM 3R; vol 5 issue 1: Jan-March 17. 28-31.
The spectrum of clinical and immunological features of systemic rheumatic diseases in a referral hospital: Juvenile Dermatomyositis/Polymyositis. JIRA 1995:3(4):141-145.
Short report: Giant cell arteritis A Clinical and Pathological Study National medical journal of India; 2010 vol 23;1; 18-20.
An unusual presentation of Wegener’s granulomatosis during pregnancy. IJRCI. 2013;1(1):CS4 (22 June 2013).
Presentation of Ewing’s sarcoma as unilateral sacroiliitis. IJRCI. 2013;1(1):CS3. (21 May 2013).
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study.
Int J Rheum Dis. 2016 Nov;19(11):1083-1092. doi: 10.1111/1756-185X.12927.
Phenotypic Variability in Majeed Syndrome. J Rheumatol 2016;43:6; doi:10.3899/jrheum.151193.
Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study. Int J Rheum Dis. 2016 Jul 25. doi: 10.1111/1756-185X.12908. [Epub ahead of print].
Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity;(KRAC) study. Int J Rheum Dis. 2016 Dec 10. doi: 10.1111/1756-185X.12957. [Epub ahead of print].
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clin Rheumatol. 2016 Dec 19. [Epub ahead of print].
Comorbidities and related factors in rheumatoid arthritis patients in south India-KRAC study. Rheumatismo 2017;69(2):47-58.
Das P, Moorthy A, Dharmanand B. Rheumatology training in India compared to the United Kingdom. Indian J Rheumatol [serial online] 2018 [cited 2018 Jun 7];13:113-6. Available from: http://www.indianjrheumatol.com/text.asp?2018/13/2/113/222116.
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
August 2018 International Journal of Rheumatic Diseases
DOI: 10.1111/1756-185X.13376
International Scleroderma Symposium: July 16–17, 2016, Bengaluru: Indian J Rheumatol 2016;11:163-4.
SAT0234 Prospective single centre study of effectiveness of upfront rituximab and mycophenolate with minimum steroid in SLE
June 2017Annals of the Rheumatic Diseases 76(Suppl 2):862.1-862
DOI: 10.1136/annrheumdis-2017-eular.2902
Conference: Annual European Congress of Rheumatology, 14–17 June, 2017
Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India. Rheumatology International
https://doi.org/10.1007/s00296-019-04245-4
Worsening of posterior scleritis and orbital pseudotumor in a patient with Granulomatosis polyangiitis with a rituximab‑A case report. Indian J Ophthalmol 2020;68:XX-XX
Expert Panel Consensus Statements on the Optimal Usage of Rituximab
for the Management of Rheumatoid Arthritis in India. Indian Journal Of Rheumatology; 10.4103/injr.injr_69_21 (2021).
Do all Patients with Rheumatic Diseases have a Higher Risk of COVID 19? Initial Results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC). Indian J Rheumatol 2021;16:164-8.
A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic Diseases; DOI: https://doi.org/10.21203/rs.3.rs-805748/v1 (Preprint).
Effectiveness of myofascial release on pain, sleep, and quality of life in
patients with fibromyalgia syndrome: A systematic review. Complementary Therapies in Clinical Practice 45 (2021) 101477.
A dire need to create awareness about rheumatological diseases - Dr. BG Dharmanand, Senior Consultant - Rheumatology, Manipal Hospital Millers Road. Click Here
Talks & Publications
Dapsone in Rheumatic Diseases (Review) Journal of Indian Rheumatology Association (JIRA) 1994:2(4): 177-179.
Interferon therapy in Rheumatic diseases (Review) JIRA 1995:3(1) 33-35.
Gastrointestinal tract in Rheumatic diseases (Review)-Antiseptic 1995
1995:92(9);336-337.
Aggressive therapy in Neuropsychiatric Lupus-Should NPSLE be treated as aggressively as renal Lupus-JIRA 1996;4(2);61-63.
Rheumatological manifestation of diabetes mellitus-Karnataka journal
of medical sciences (KJMS) April-June 2002.
Rheumatological manifestations in Hypothyroidism-JK Science Vol 3: no 3, July-September 2001.
International scleroderma symposium: July 16-17, 2016, Bengaluru. Indian J Rheumatol 2016;11:163-4.
Preface: Soft Tissue Rheumatism Indian Journal of Rheumatology 9 ( 2 0 1 4 ) S 1eS 2.
Approach to a patient with soft tissue rheumatic pain.. Ind J Rheumatol. 2014;9:S3eS5.
Polymyalgia Rheumatica and Giant cell arteritis. JIM 3R; vol 5 issue 1: Jan-March 17. 28-31.
The spectrum of clinical and immunological features of systemic rheumatic diseases in a referral hospital: Juvenile Dermatomyositis/Polymyositis. JIRA 1995:3(4):141-145.
Short report: Giant cell arteritis A Clinical and Pathological Study National medical journal of India; 2010 vol 23;1; 18-20.
An unusual presentation of Wegener’s granulomatosis during pregnancy. IJRCI. 2013;1(1):CS4 (22 June 2013).
Presentation of Ewing’s sarcoma as unilateral sacroiliitis. IJRCI. 2013;1(1):CS3. (21 May 2013).
Efficacy and safety of golimumab in Indian patients with rheumatoid arthritis: Subgroup data from GO-MORE study.
Int J Rheum Dis. 2016 Nov;19(11):1083-1092. doi: 10.1111/1756-185X.12927.
Phenotypic Variability in Majeed Syndrome. J Rheumatol 2016;43:6; doi:10.3899/jrheum.151193.
Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study. Int J Rheum Dis. 2016 Jul 25. doi: 10.1111/1756-185X.12908. [Epub ahead of print].
Reduced incidence of extra-articular manifestations of RA through effective disease control: Karnataka Rheumatoid Arthritis Comorbidity;(KRAC) study. Int J Rheum Dis. 2016 Dec 10. doi: 10.1111/1756-185X.12957. [Epub ahead of print].
Latitude gradient influences the age of onset of rheumatoid arthritis: a worldwide survey. Clin Rheumatol. 2016 Dec 19. [Epub ahead of print].
Comorbidities and related factors in rheumatoid arthritis patients in south India-KRAC study. Rheumatismo 2017;69(2):47-58.
Das P, Moorthy A, Dharmanand B. Rheumatology training in India compared to the United Kingdom. Indian J Rheumatol [serial online] 2018 [cited 2018 Jun 7];13:113-6. Available from: http://www.indianjrheumatol.com/text.asp?2018/13/2/113/222116.
Biologics and risk of tuberculosis in autoimmune rheumatic diseases: A real-world clinical experience from India.
August 2018 International Journal of Rheumatic Diseases
DOI: 10.1111/1756-185X.13376
International Scleroderma Symposium: July 16–17, 2016, Bengaluru: Indian J Rheumatol 2016;11:163-4.
SAT0234 Prospective single centre study of effectiveness of upfront rituximab and mycophenolate with minimum steroid in SLE
June 2017Annals of the Rheumatic Diseases 76(Suppl 2):862.1-862
DOI: 10.1136/annrheumdis-2017-eular.2902
Conference: Annual European Congress of Rheumatology, 14–17 June, 2017
Incidence of infection other than tuberculosis in patients with autoimmune rheumatic diseases treated with bDMARDs: a real-time clinical experience from India. Rheumatology International
https://doi.org/10.1007/s00296-019-04245-4
Worsening of posterior scleritis and orbital pseudotumor in a patient with Granulomatosis polyangiitis with a rituximab‑A case report. Indian J Ophthalmol 2020;68:XX-XX
Expert Panel Consensus Statements on the Optimal Usage of Rituximab
for the Management of Rheumatoid Arthritis in India. Indian Journal Of Rheumatology; 10.4103/injr.injr_69_21 (2021).
Do all Patients with Rheumatic Diseases have a Higher Risk of COVID 19? Initial Results from the Karnataka Rheumatology Association COVID 19 Cohort Study (KRACC). Indian J Rheumatol 2021;16:164-8.
A Prospective Longitudinal Study Evaluating The Influence of Immunosuppressives and Other Factors On COVID-19 in Autoimmune Rheumatic Diseases; DOI: https://doi.org/10.21203/rs.3.rs-805748/v1 (Preprint).
Effectiveness of myofascial release on pain, sleep, and quality of life in
patients with fibromyalgia syndrome: A systematic review. Complementary Therapies in Clinical Practice 45 (2021) 101477.
A dire need to create awareness about rheumatological diseases - Dr. BG Dharmanand, Senior Consultant - Rheumatology, Manipal Hospital Millers Road. Click Here
Fellowship & Membership
IMA
API
IAPMR
Geriatric society.
Society of orthopaedic medicine.
IACFS-ME
Fascia research society.
IOF
Indian Rheumatology association.
Field of Expertise
Arthritis
Multi-system autoimmune diseases
Osteoporosis
Fibromyalgia and Musculoskeletal medicine
Languages Spoken
English
Tamil
Kannada
Telugu
Hindi
Awards & Achievements
President, Indian Rheumatology Association (2021-2023).
Scientific committee chairman: IRACON 2021.
The benefits of Prime Access OPS are as below:
Minimal Waiting Time for Consultations.
Exclusive Waiting Area
Personal Attention.
Fast tracked Services.
Refund Policy
1) Up to 4 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation can be done with full refund of the payment.
2) Up to 2 hrs of appointment time:
Rescheduling of doctor appointment can be done within a week from the date of appointment as per doctor / slot availability.
Cancellation of appointment and refund with a cancellation charge of Rs.100/-.
3) Less than 2 hrs of appointment time:
Rescheduling / cancellation of appointment cannot be done, payment non-refundable in this case. However, Units can have the discretion to refund / reschedule in case of exigencies.
Please note : While making the payment online, above mentioned payment terms and conditions should be agreed upon by customers, by clicking in a box ( I agree) and then proceed for payment.
PATIENT CONSENT FOR TELEMEDICINE / TELECONSULTATION
Telemedicine involves the use of electronic communications to enable Hospitals/health care centres to provide healthcare services at different locations through exchange of information and for the purpose of improving patient care. I, confirm that I have received the necessary information to sign this form and I agree to take part in a live telemedicine/teleconsultation session with Manipal Hospitals.
I understand that:
Interactive audio/video connection, electronic information and communication technologies shall be used for providing me with a telemedicine/teleconsultation.
In case the information obtained via teleconsultation is not sufficient to make a diagnosis, I may be required to go to Manipal Hospitals for in-person consultation.
Though the telemedicine/teleconsultation is private, other individuals, medical and non-medical, may be present to facilitate the consultation and that they will take reasonable steps to maintain confidentiality of the information obtained.
A limited visual examination will take place during the telemedicine/teleconsultation and that it cannot replace a full medical examination done physically at Manipal Hospitals.
I have the right to withhold or withdraw my consent to the use of telemedicine/teleconsultation in the course of my care at any time, without affecting my right to future care or treatment. I may also revoke my consent orally or in writing at any time.
I may be prescribed medicines for treatment or/and diagnostic tests to further evaluate my health condition. All prescription will be sent to my registered email/phone no. Manipal Hospitals will keep a record of the consultation & prescription in my medical record.
The telemedicine/teleconsultation services are not in any way intended to be used in case of an emergency.
There can be potential risks with this technology e.g information transmitted may not be sufficient to allow for appropriate medical decision, the video /audio may disconnect/stop in-between, security protocols could fail causing a breach of privacy of personal medical information.
Any relevant medical information about me including details of my medical history, examinations, x-rays, tests, photographs or other images may be transmitted /shared by Manipal Hospitals with their staff, specialist, business partners for the purpose of record, communications, feedback, enquires, follow ups, analysis etc.
Manipal Hospitals responsibility shall terminate upon conclusion of this teleconference.
I hereby consent that in consideration for the telemedicine / teleconsultation services rendered to me, I agree to pay the relevant charges.
I hereby release Manipal Hospitals, its personnel and any other person participating in my care from any and all liability which may arise from authorized use of such Video / E-Consultation, Videotapes, Digital recording films and Photographs. I have read this document and understand the risk of the telemedicine / teleconsultation.
I hereby consent to participate in a telemedicine / teleconsultation under the terms & conditions described in this document.